The pivotal trial for Neurogene's Rett syndrome gene therapy makes use of baseline controls and a rigorous endpoint that ...

Pfizer Inc (($PFE)) announced an update on their ongoing clinical study. Pfizer Inc. is initiating a Phase 1 clinical study titled A PHASE 1, ...

The Federal Government of Nigeria, through the National Institute for Cancer Research and Treatment (NICRAT), on Tuesday ...

Currently available treatments for IPF are limited to only two approved drugs that come with significant side-effects, ...

ST-100 shows promise as a fast-acting treatment for dry eye disease, offering rapid relief and unique collagen repair ...

As federal grants to study the use of race in clinical algorithms dry up researchers are looking for other funding sources.

Brian Ongioni, chief product officer, uMotif, discusses how AI and machine learning can enhance patient-reported outcomes by ...

At ASCO 2025, clinical operations leaders gained critical insights into how AI tools, bispecific antibodies, and evolving ...

Sanaregen Vision Therapeutics invites investors to reserve shares as it prepares for an equity crowdfunding campaign to advance retinal disease treatments.

Eight researchers specializing in adult oncology from Fred Hutch Cancer Center and the University of Washington have been ...

A scientific message will not resonate unless viewers have clear reason to care about the issue and, more importantly, to ...